Researchers identify a process responsible for therapeutic resistance in breast cancer

Researchers at the Lady Davis Institute have identified a key protein that is required for resistance to chemotherapy in the most aggressive form of breast cancer. This holds the promise of opening the door to new therapies for overcoming drug resistance. Using tumor biopsies from patients with chemotherapeutic resistant triple negative breast cancer (TNBC), researchers…

Details

The Intersection of Innovation and Practice Heads to Atlanta

WASHINGTON – Registration is now open for the Society for Cardiovascular Angiography & Interventions (SCAI) 2020 Scientific Sessions. The three-day conference will take place May 13-16, 2020, at the Hyatt Regency in Atlanta, Georgia. SCAI 2020 will attract nearly 2,000 leading physicians, cardiovascular professionals, hospital administrators, academia, and industry professionals from around the globe. World-renowned…

Details